A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Metastases|Radiotherapy
Interventions: DRUG: Combination use of SRT with T-DXd
Sponsor: Fudan University